EPTAM Precision Solutions Names Bill Flaherty as Chief Commercial Officer

EPTAM Precision Solutions Names Bill Flaherty as Chief Commercial Officer

July 9, 2024

Northfield, NH – EPTAM Precision Solutions (“EPTAM” or the “Company”), a Frazier Healthcare Partners (“Frazier”) portfolio company, is pleased to announce the appointment of William (Bill) Flaherty as its new Chief Commercial Officer (CCO), effective July 8, 2024. As a key addition to EPTAM’s leadership team, Bill will play a crucial role in driving EPTAM’s commercial growth and strategic market expansion.

Founded in 1981, EPTAM is an outsourced manufacturer of medical device components, single-use disposables and finished device assemblies. EPTAM’s services include manufacturing implants, minimally invasive & robotic assisted surgical instruments, interventional and structural heart components, single-use medical disposables, biopharma processing equipment components, and molecular diagnostic testing cartridges, as well as other high-precision surgical device components. The Company has expertise with polymer machining, precision metal machining, injection molding, liquid silicon rubber molding, laser cutting/welding, and metal injection molding. Additionally, EPTAM offers a wide range of value-added services such as rapid-prototyping, process development & validation, design-for-assembly, cleanroom assembly, laser cutting/welding equipment development and overall technical program management. EPTAM has over 650 employees with operations in New Hampshire, Massachusetts, New Jersey, Connecticut, Michigan, Minnesota, and Colorado.

Bill brings a distinguished career and a wealth of experience in leadership positions across the large Public Company,  Private Equity and Contract Manufacturing ecosystems to EPTAM. He joins the Company from LongueVue Capital Partners, where he served as an Operating Partner focused on the MedTech industry. His pragmatic and resourceful approach has been instrumental in driving value creation for both middle-market and large-tier companies. Prior to LongueVue, Bill was the CEO of iiMED MEDICAL, CCO of Viant Medical, Divisional President of Vention Medical and President of Flex Medical where he achieved significant revenue and EBITDA growth and successfully delivered on strategic growth initiatives.

“In Bill Flaherty, EPTAM is extremely fortunate to partner with an exceptional commercial leader who brings a proven track record of driving revenue growth and market expansion” stated Mark Kemp, CEO of EPTAM Precision Solutions. “Bill’s extensive background in the MedTech Contract Manufacturing and Industrial Manufacturing sectors, coupled with his strategic vision and operational acumen, makes him the ideal leader to drive our commercial efforts and support our mission of delivering exceptional precision manufacturing solutions to our clients.  In his role as Chief Commercial Officer, Bill will join our Executive team and oversee the entire commercial organization, including  Business Development, Program Management, Inside Sales Team, Manufacturer’s Representatives and our Marketing initiatives. His leadership, strategic vision, and extensive experience in driving revenue growth, customer relationship development and market expansion will be invaluable as we navigate the next phase of growth and innovation at EPTAM.”

Bill added, “I am excited to join the EPTAM team and be part of such a dynamic and innovative organization. I look forward to contributing to EPTAM’s growth and working closely with our dedicated team to achieve our strategic goals.”

About EPTAM Precision Solutions

EPTAM is a leading high-precision outsourced manufacturer of complex components and devices with particular expertise in plastic, metal, and injection molded applications. The company provides its custom machining solutions to leaders in the Medical Devices, BioPharma, and Diversified Industrials sectors. Please visit www.eptam.com for more details about the company and its diverse portfolio of services.

About Frazier Healthcare Partners

Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over $8 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over 32 years. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier is headquartered in Seattle, WA, and invests broadly across the U.S., Canada, and Europe. For more information about Frazier, visit www.frazierhealthcare.com